Effect of alpha-lipoic acid on asymmetric dimethylarginine and disability in multiple sclerosis patients: A randomized clinical trial
Background: Multiple Sclerosis (MS) is an inflammatory and demyelinating disease of the central nervous system. Oxidative stress plays a major role in the onset and progression of MS. Asymmetric dimethylarginine (ADMA) formation is dependent on oxidative stress status. Objective: We examined whet...
Main Authors: | Mohammad Khalili, Madjid Soltani, Shirin Amiri Moghadam, Parvin Dehghan, Amirreza Azimi, Omid Abbaszadeh |
---|---|
Format: | Article |
Language: | English |
Published: |
Electronic Physician
2017-07-01
|
Series: | Electronic Physician |
Subjects: | |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587011/ |
Similar Items
-
Endothelial dysfunction in multiple sclerosis and management options using alpha-lipoic acid
by: N. N. Spirina, et al.
Published: (2015-12-01) -
New opportunities for the use of alpha-lipoic acid: the role of enantiomers
by: T.Yu. Yuzvenko, et al.
Published: (2019-09-01) -
Diabetes and alpha lipoic acid
by: Issy eLaher
Published: (2011-11-01) -
Alpha lipoic acid: A treatment option for diabetic patients with Covid 19
by: Hossein Bahrami Moghadam, et al.
Published: (2021-06-01) -
The Health Effects of Alpha Lipoic Acid
by: Armağan Yürük, et al.
Published: (2014-12-01)